Order Article Reprints

Cardama GA, Bucci PL, Lemos JS, Llavona C, Benavente MA, Hellmén E, Fara ML, Medrano E, Spitzer E, Demarco IA, et al. In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma. Animals. 2023; 13(15):2507. https://doi.org/10.3390/ani13152507

Cardama, Georgina A., Paula L. Bucci, Jesús S. Lemos, Candela Llavona, Micaela A. Benavente, Eva Hellmén, María Laura Fara, Eduardo Medrano, Eduardo Spitzer, Ignacio A. Demarco, and et al. 2023. "In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma" Animals 13, no. 15: 2507. https://doi.org/10.3390/ani13152507

Cardama, G. A., Bucci, P. L., Lemos, J. S., Llavona, C., Benavente, M. A., Hellmén, E., Fara, M. L., Medrano, E., Spitzer, E., Demarco, I. A., Sabella, P., Garona, J., & Alonso, D. F. (2023). In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma. Animals, 13(15), 2507. https://doi.org/10.3390/ani13152507